Clinical Impact of Additional Cytogenetic Aberrations, cKIT and RAS Mutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group

PURPOSE: This retrospective cohort study aimed to determine the predictive relevance of clinical characteristics, additional cytogenetic aberrations, and cKIT and RAS mutations, as well as to evaluate whether specific treatment elements were associated with outcomes in pediatric t(8;21)-positive pat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Klein, Kim, Kaspers, Gertjan, Harrison, Christine J., Beverloo, H. Berna, Reedijk, Ardine, Bongers, Mathilda, Cloos, Jacqueline, Pession, Andrea, Reinhardt, Dirk, Zimmerman, Martin, Creutzig, Ursula, Dworzak, Michael, Alonzo, Todd, Johnston, Donna, Hirsch, Betsy, Zapotocky, Michal, De Moerloose, Barbara, Fynn, Alcira, Lee, Vincent, Taga, Takashi, Tawa, Akio, Auvrignon, Anne, Zeller, Bernward, Forestier, Erik, Salgado, Carmen, Balwierz, Walentyna, Popa, Alexander, Rubnitz, Jeffrey, Raimondi, Susana, Gibson, Brenda
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2015
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5321085/
https://ncbi.nlm.nih.gov/pubmed/26573082
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.61.1947
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars